CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,200,925 | +178.5% | 102,731 | +295.0% | 0.04% | +144.4% |
Q1 2023 | $431,262 | -12.2% | 26,011 | -32.0% | 0.02% | -41.9% |
Q3 2022 | $491,000 | +16.4% | 38,274 | -36.5% | 0.03% | +106.7% |
Q2 2022 | $422,000 | +22.7% | 60,239 | +45.3% | 0.02% | +15.4% |
Q1 2022 | $344,000 | +319.5% | 41,445 | +169.2% | 0.01% | +160.0% |
Q3 2021 | $82,000 | -69.1% | 15,395 | -66.6% | 0.01% | -70.6% |
Q2 2021 | $265,000 | +2.7% | 46,103 | -17.8% | 0.02% | +30.8% |
Q1 2021 | $258,000 | +486.4% | 56,066 | +324.9% | 0.01% | +550.0% |
Q4 2020 | $44,000 | -93.3% | 13,196 | -94.0% | 0.00% | -93.5% |
Q3 2020 | $657,000 | +926.6% | 221,358 | +1387.4% | 0.03% | +244.4% |
Q1 2015 | $64,000 | – | 14,882 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |